---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-052679"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:23:00.950603+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tivic Health regains Nasdaq minimum bid price compliance; stock continues listing

## Summary
- Received Nasdaq confirmation on April 4, 2025 that minimum bid price compliance is regained.
- Reverse stock split implemented on March 7, 2025 as required by Nasdaq Hearings Panel.
- Company had been notified of deficiency in June 2024 and received extension through panel decision.
- Common stock (TIVC) continues trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0000950170-25-052679
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025052679/0000950170-25-052679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025052679/tivc-20250404.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-052679
- JSON: https://secwatch.observer/filing/0000950170-25-052679.json
- Plain text: https://secwatch.observer/filing/0000950170-25-052679.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.